Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Active not recruiting 3Not yet recruiting 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1

Conditions

Respiratory Sounds 1Leukemia 1Hypoxia 1Edema 1Dyspnea, Paroxysmal 1Dyspnea 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Furosemide × Clear all
NCT01508260 2013-04-05

Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload

M.D. Anderson Cancer Center

Phase NA Withdrawn
OtherOther hematologic neoplasm

Hypoxia, Dyspnea, Dyspnea, Paroxysmal, Edema, Leukemia, Respiratory Sounds

Data powered by HemOnc (CC BY 4.0) Colophon âš¡